An interventional study of Pilates and Combined Resistance and Aerobic Training in Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis), sponsored by Szeged University. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-09.
Sponsored by Szeged University · Not applicable, Interventional, and Supportive care
The goal of this randomized controlled trial is to evaluate the effects of two different exercise programs, Pilates and combined resistance and aerobic training, on physical activity, kinesiophobia, quality of life, and disease-related outcomes in adults with inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis.
The main questions it aims to answer are:
Researchers will compare participants assigned to the Pilates group and the combined resistance and aerobic training group with participants in the control group to evaluate the effects of the exercise programs.
Participants will be randomly allocated to one of three groups: a Pilates group, a combined resistance and aerobic training group, or a control group. Participants in the exercise groups will follow their assigned exercise program using online instructional videos twice a week for 12 weeks, with each session lasting 20-30 minutes. They will record completed exercise sessions in an exercise diary. All participants will complete questionnaires before and after the intervention to assess physical activity, kinesiophobia, quality of life, depressive symptoms, knowledge of physical activity, and attitudes towards physiotherapists. Relevant demographic and clinical data will also be collected from medical records.
1,853 studies on the registry are indexed under Colitis, Ulcerative; 472 are open to participants now.
This study's planned enrollment of 150 is above the median of 70 across 1,236 interventional studies indexed under Colitis, Ulcerative.
Browse Colitis, Ulcerative studies →Szeged University is the lead sponsor of 56 studies on the registry; 8 are open to participants now.
Compared within Colitis, Ulcerative, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Inflammatory Bowel Diseases. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Age >18 years
Exclusion Criteria:
Presence of comorbidities
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Other: Pilates
Other: Combined Resistance and Aerobic Training
The interventions in this study are distinguished by the use of two different physiotherapist-designed, structured exercise programs delivered through online instructional videos to adults with inflammatory bowel disease (IBD). Both programs will be performed twice weekly for 12 weeks, with each session lasting 20-30 minutes. The Pilates intervention emphasizes controlled movements, breathing techniques, postural correction, stability, mobility, and strengthening of the abdominal, back, and gluteal muscles.
The interventions in this study are distinguished by the use of two different physiotherapist-designed, structured exercise programs delivered through online instructional videos to adults with inflammatory bowel disease (IBD). Both programs will be performed twice weekly for 12 weeks, with each session lasting 20-30 minutes. The combined resistance and aerobic training intervention includes strengthening exercises targeting all major muscle groups, using body weight and everyday household items, with exercises performed at varying intensities and instructions for manual heart rate monitoring.
Change in kinesiophobia level
Change in kinesiophobia level from baseline to the end of the 12-week intervention, assessed using the Tampa Scale for Kinesiophobia (TSK), a 17-item questionnaire with total scores ranging from 17 to 68, where higher scores indicate a higher level of kinesiophobia (worse outcome). Changes in kinesiophobia will be compared between the Pilates group, the combined resistance and aerobic training group, and the control group.
Time frame: Baseline and at 12 weeks
No study locations are listed for this record.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Szeged University